Navigation Links
First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes

-- Additional Findings Reported on Glucose Homeostasis Effects in Normal and Diabetic Rats --

CHICAGO, June 25, 2007 /PRNewswire-FirstCall/ -- In a 14-day, Phase IIa study of the safety profile of multiple doses of the investigational compound dapagliflozin, a selective inhibitor of the Sodium-Glucose Transporter 2 (SGLT2) administered alone or concomitantly with metformin in subjects with Type 2 diabetes, no discontinuations due to adverse events and no serious adverse events were reported. The study, presented this week at the annual meeting of the American Diabetes Association, also reported that dapagliflozin, in development by Bristol-Myers Squibb Company and AstraZeneca , statistically significantly reduced fasting serum glucose (FSG) and post challenge glucose excursion in subjects with Type 2 diabetes.

The data were from a double-blind, placebo-controlled, randomized, parallel-group study of 47 subjects with an established diagnosis of Type 2 diabetes (ages 18-77) who were either drug-naive or on a stable dose of metformin for at least 4 weeks prior to randomization with hemoglobin A1C levels between 6 and 10 percent with a FSG of less than or equal to 240 mg/dL. Subjects were randomized to receive either placebo (n=8) or dapagliflozin 5 mg (n=11), 25 mg (n=12), or 100 mg (n=16) once daily for 14 days in addition to their stable metformin dose and/or diet alone in an in-patient clinical research unit. The primary endpoint of the study was to assess both the safety and tolerability profiles of multiple doses of dapagliflozin in subjects with Type 2 diabetes. The secondary endpoints of the study included assessing the fasting serum glucose and post challenge glucose excursion. The presentation, "Dapagliflozin, a Selective Inhibitor of the Sodium-Glucose Uptake Transporter 2 (SGLT2), Reduces Fasting Serum Glucose and Glucose Excursion in Type 2 Diabetes Mellitus Patients Over 14 Days", was presented by Bernard Komoroski, PharmD, Ph.D., Senior Research
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
4. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
5. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
6. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
7. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
8. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
9. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
10. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
11. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
Post Your Comments:
(Date:7/27/2015)... , July 20, 2015 Research and ... of the "D-dimer Testing Market - Global ... Forecast 2014 - 2022" report to their ... vitro diagnostics market is one of the fastest ... attributed to the improved health care awareness, preference ...
(Date:7/27/2015)... -- Dynatronics Corporation (NASDAQ: DYNT ) today announced it has ... approval allows the company to sell these products in ... "Receiving the CE Mark represents the achievement of an important ... Jr. , president and CEO of Dynatronics. "Over the past several ... , Japan , Mexico ...
(Date:7/27/2015)... British Columbia and MENLO ... --  DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" ... developing and commercializing proven cancer therapies in new ... accepted subscriptions from institutional and accredited investors for ... shares of common stock and 3.35 million common ...
Breaking Medicine Technology:D-dimer Testing Market - Global Industry Analysis 2015 2D-dimer Testing Market - Global Industry Analysis 2015 3Dynatronics Awarded CE Mark Approval for Its Solaris Products 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 2DelMar Pharmaceuticals Announces Financing Update and Initial Subscriptions of $2.0 million in Registered Direct Offering 3
... Dec. 8, 2010 Reportlinker.com announces that a new ... Europe Neurology Devices Market Outlook to 2016 ... Neurology Devices Market Outlook to 2016 ... 2016" provides key market data on the Europe Neurology ...
... Reportlinker.com announces that a new market research ... Asia-Pacific Dental Devices Market Outlook to 2016 ... Asia-Pacific Dental Devices Market Outlook to 2016 ... Devices Market Outlook to 2016" provides key market ...
Cached Medicine Technology:Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 2Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 3Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 4Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 5Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 6Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 7Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 8Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 9Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 10Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 11Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 12Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 13Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 14Reportlinker Adds Europe Neurology Devices Market Outlook to 2016 15Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 2Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 3Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 4Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 5Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 6Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 7Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 8Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 9Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 10Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 11Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 12Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 13Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 14Reportlinker Adds Asia-Pacific Dental Devices Market Outlook to 2016 15
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... Treatment Center has added hiking to its options. Already an industry ... Palms is constantly on the lookout for the latest successful trends in helping ...
(Date:7/27/2015)... ... July 27, 2015 , ... At Champagne Smiles, they know that tooth ... can incur a lot of stress, pain, discomfort and embarrassment, which is why they ... treatment reaps the benefits of implants with the cost savings of dentures for anyone ...
(Date:7/27/2015)... ... July 27, 2015 , ... Hexagon Geospatial is ... to understand and share your geospatial experience. These new light-weight applications cohesively combine ... distinct business problems. , “Our world is more dynamic than it has ever ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... Boston IVF, ... birth, will host an educational "Happy Hour" on Nantucket Island for women who ... August 6 at Grey Lady Restaurant and Bar, 2 Chins Way, Nantucket Island 02554 ...
(Date:7/27/2015)... ... 27, 2015 , ... Rountree Brady Insurance Agency, a locally ... new charity drive to support Next Generation, a volunteer group that works to ... , Next Generation workers are dedicated to improving the lives and outlooks of ...
Breaking Medicine News(10 mins):Health News:Hiking Adds Benefits to Recovery at Serenity Palms 2Health News:Hiking Adds Benefits to Recovery at Serenity Palms 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 2Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 3Health News:NJ Top Dentists Presents, Dr. Richard Champagne of Champagne Smiles! 4Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 2Health News:Hexagon Geospatial Visualizes Stories with the Hexagon Smart M.App® 3Health News:Boston IVF to Host Egg Freezing Event in Nantucket on August 6th at 4:30pm 2Health News:Boston IVF to Host Egg Freezing Event in Nantucket on August 6th at 4:30pm 3Health News:Rountree Brady Announces Charity Effort to Support Children’s Services at the Memorial University Medical Center Hospital 2Health News:Rountree Brady Announces Charity Effort to Support Children’s Services at the Memorial University Medical Center Hospital 3
... ... Management Project , ... Chicago (PRWEB) June 11, 2009 -- The Critical Access Hospital (CAH) Quality Network of ... healthcare risk, quality and patient safety software and consulting services have joined forces to ...
... it) more, experts say, , THURSDAY, June 11 (HealthDay News) -- ... shape, all you need is a four-legged pal. , Dr. ... Northwestern University,s Feinberg School of Medicine, said that dogs make great ... are natural exercise machines on a leash," he said. , Research ...
... DENVER, June 11 Birner Dental Management Services, Inc. ... PERFECT TEETH dental practices, announced its regular quarterly ... quarterly cash dividend of 17 cents per share of common ... shareholders of record June 26, 2009. , , Birner ...
... strong record of revenue growth and sales force development , ... Bulletin Board: XELR), a provider of functional foods, beverages and ... for the role of Vice President - Strategy and Network ... of XELR8 said, "We are excited to add Kevin,s strong ...
... , SAN DIEGO, June 11 Orexigen(R) Therapeutics, Inc. ... on the treatment of obesity, today announced the licensing ... expands the Company,s IP position underlying Contrave, its lead ... , "This license agreement with GSK complements the IP ...
... Wis., June 11 Health plan transparency has gained ... "quest" to have better information to make informed health ... quality is often discussed in the form of better ... in reporting on member and claims disruption. The health ...
Cached Medicine News:Health News:North Dakota Critical Access Hospital Quality Network Moves Forward with Statewide Information Management Project to Enhance Patient Safety in the State 2Health News:North Dakota Critical Access Hospital Quality Network Moves Forward with Statewide Information Management Project to Enhance Patient Safety in the State 3Health News:Need a Walking Partner? Try a Dog 2Health News:Need a Walking Partner? Try a Dog 3Health News:XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development 2Health News:XELR8 Holdings, Inc. Hires Vice President of Strategy and Network Development 3Health News:Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R) 2Health News:Orexigen(R) Therapeutics Announces In-Licensing of Key Patents to Further Strengthen its Intellectual Property Estate for Contrave(R) 3Health News:Moving Beyond the Mysteries of Disruption Reporting 2
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
Medicine Products: